期刊
ACS BIOMATERIALS SCIENCE & ENGINEERING
卷 8, 期 4, 页码 1613-1622出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsbiomaterials.1c01374
关键词
cell therapy; injectable hydrogel; atopic dermatitis; mesenchymal stem cell; hyaluronic acid
资金
- National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2021R1A4A2001827]
- Basic Research Program of National Research Foundation of Korea (NRF) - Ministry of Science and ICT of Republic of Korea [NRF-2020R1A6A3A01096234]
- BK21 FOUR program through the National Research Foundation of Korea (NRF) - Ministry of Education, Korea
Stem cell therapies have great potential in regenerative medicine to restore normal tissue function. In this study, injectable hydrogels were developed to improve the efficacy of mesenchymal stem cells for treating inflammatory lesions. The hydrogels showed high cell viability and good biocompatibility, and increased expression of anti-inflammatory cytokines. In an animal model, the hydrogels reduced inflammation-related damage.
Stem cell therapies offer great promise in regenerative medicine to reinstate the normal function of diseased tissue, there by avoiding the need for replacement. In stem cell therapies, damaged cellsare replaced or restored by regulating inflammation and the immune system. However, the low survival rate and local retention of transplanted cells pose a significant challenge. In this study, injectable self-crosslinkable hydrogels using thiol-functionalized hyaluronic acid (HA-SH) were developed to improve the efficacy of mesenchymal stem cells(MSCs) for treating atopic dermatitis (AD)-related inflammatory lesions.The gelation kinetics and mechanical properties of HA-SH hydrogels were easily tuned by varying the concentration of the polymerin the precursor solution before injection. The MSC-laden HA-SH hydrogels exhibited high cell viability (>80%) for 1 week andgoodin vivobiocompatibility after implantation beneath the mouse skin. Moreover, the MSC-laden HA-SH hydrogel showedincreased expression of anti-inflammatory cytokines, which can alleviate the immune response. In an AD animal model, a reduction in epidermal thickness and mast cell infiltration was achieved by applying a self-crosslinkable HA-SH solution including MSCs. This HA-based injectable hydrogel represents a potential carrier of stem cells, and its strong immunomodulation capabilities can beutilized for treating inflammation-related diseases
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据